Rap2 belongs to the Ras family of small GTP-binding proteins, but its specific roles in cell signaling remain unknown. In the present study, we have affinity-purified from rat brain a Rap2-interacting protein of ϳ155 kDa, p155. By liquid chromatography tandem mass spectrometry, we have identified p155 as Traf2-and Nck-interacting kinase (TNIK). TNIK possesses an N-terminal kinase domain homologous to STE20, the Saccharomyces cerevisiae mitogen-activated protein kinase kinase kinase kinase, and a C-terminal regulatory domain termed the citron homology (CNH) domain. TNIK induces disruption of F-actin structure, thereby inhibiting cell spreading. In addition, TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway. Among our observations, TNIK interacted with Rap2 through its CNH domain but did not interact with Rap1 or Ras. TNIK interaction with Rap2 was dependent on the intact effector region and GTP-bound configuration of Rap2. When co-expressed in cultured cells, TNIK colocalized with Rap2, while a mutant TNIK lacking the CNH domain did not. Rap2 potently enhanced the inhibitory function of TNIK against cell spreading, but this was not observed for the mutant TNIK lacking the CNH domain. Rap2 did not significantly enhance TNIKinduced JNK activation, but promoted autophosphorylation and translocation of TNIK to the detergentinsoluble cytoskeletal fraction. These results suggest that TNIK is a specific effector of Rap2 to regulate actin cytoskeleton.Rap2 is a member of the Ras family of small GTP-binding proteins, which regulate a range of cellular processes including cell proliferation, differentiation, and cytoskeletal rearrangement (for a review, see Ref. 1). To regulate these processes, Ras family proteins cycle between GTP-bound active and GDPbound inactive forms. In the GTP-bound active form, Ras family proteins physically interact with downstream effectors and thereby regulate their subcellular localization and activity (1). For instance, GTP-bound Ras interacts with effectors including Raf-1, B-raf, Ral guanine nucleotide dissociation stimulator During interaction with effectors, the effector regions of Ras family proteins (amino acids 32-40 in the case of Ras) serve as binding interfaces; thus, mutations within their effector regions impair interaction with effectors (Refs. 1-4, reviewed in Ref. 6). The effector regions are also critical for the differential recognition of effectors. For instance, the effector region of Rap1, a close relative of Rap2, is identical to that of Ras. Rap1 interacts with effectors of Ras, and sometimes counteracts Rasmediated signaling (1, 2). For example, Rap1 regulates the extracellular signal-regulated kinase (ERK) pathway, the "classical" mitogen-activated protein kinase (MAPK) pathway, through Raf-1 and B-raf. Although Rap1 interacts with Raf-1 and B-raf, it only activates B-raf. In fibroblasts, Rap1 inhibits Ras-induced cellular transformation. Rap1 exerts this action presumably by trapping Raf-1 in an inactive complex, thereby inhibiting ERK activation (1...

Forty-six pediatric patients who underwent living donor liver transplantation (LDLT) using parental liver grafts for inheritable metabolic disorders (IMD) were evaluated to determine the outcomes of the surgery, decisive factors for post-transplant patient survival and the impact of using donors who were heterozygous for the particular disorder. Disorders included Wilson disease (WD, n = 21), ornithine transcarbamylase deficiency (OTCD, n = 6), tyrosinemia type I (TTI, n = 6), glycogen storage disease (GSD, n = 4), propionic acidemia (PPA, n = 3), methylmalonic acidemia (MMA, n = 2), Crigler-Najjar syndrome type I (CNSI, n = 2), bile acid synthetic defect (BASD, n = 1) and erythropoietic protoporphyria (EPP, n = 1). The post-transplant cumulative patient survival rates were 86.8 and 81.2% at 1 and 5 years, respectively. Posttransplant patient survival and recovery of the growth retardation were significantly better in the liveroriented diseases (WD, OTCD, TTI, CNSI and BASD) than in the non-liver-oriented diseases (GSD, PPA, MMA and EPP) and pre-transplant growth retardation disadvantageously affected post-transplant outcomes. Although 40 of 46 donors were considered heterozygous for each disorder, neither mortality nor morbidity related to the heterozygosis has been observed. LDLT using parental donors can be recommended as an effective treatment for pediatric patients with IMD. In the non-liver-oriented diseases, however, satisfactory outcomes were not obtained by hepatic replacement alone.

To address the current role of liver transplantation (LT) for urea cycle disorders (UCDs), we reviewed the worldwide English literature on the outcomes of LT for UCD as well as 13 of our own cases of living donor liver transplantation (LDLT) for UCD. The total number of cases was 51, including our 13 cases. The overall cumulative patient survival rate is presumed to be more than 90% at 5 years.

Little is known about the specific signaling roles of Rap2, a Ras family small GTP-binding protein. In a search for novel Rap2-interacting proteins by the yeast two-hybrid system, we isolated isoform 3 of the human mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), a previously described but uncharacterized isoform. Other isoforms of MAP4K4 in humans and mice are known as hematopoietic progenitor kinase (HPK)/ germinal center kinase (GCK)-like kinase and Nck-interacting kinase, respectively. MAP4K4 belongs to the STE20 group of protein kinases and regulates c-Jun Nterminal kinase (JNK). MAP4K4 interacted with Rap2 through its C-terminal citron homology domain but did not interact with Rap1 or Ras. Interaction with Rap2 required the intact effector region of Rap2. MAP4K4 interacted preferentially with GTP-bound Rap2 over GDP-bound Rap2 in vitro. In cultured cells, MAP4K4 colocalized with Rap2, while a mutant MAP4K4 lacking the citron homology domain failed to do so. Furthermore, Rap2 enhanced MAP4K4-induced activation of JNK. These results suggest that MAP4K4 is a putative effector of Rap2 mediating the activation of JNK by Rap2.Rap2 belongs to the Ras family of small GTP-binding proteins. The mammalian Ras family consists of Ras proteins (Ha-Ras, Ki-Ras, and N-Ras), Rap proteins (Rap1A, Rap1B, Rap2A, and Rap2B), R-Ras, R-Ras2/TC21, R-Ras3/M-Ras, Ral proteins (RalA and RalB), Rheb, Rin, and Rit (for a review, see Ref.